Kollias AN, Ulbig MW. Diabetic Retinopathy. Dtsch Arztebl Int. 2010;107:75–84.

PubMed  PubMed Central  Google Scholar 

Teo ZL, Tham YC, Yu M, Chee ML, Rim TH, Cheung N, et al. Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis. Ophthalmology 2021;128:1580–91.

Article  PubMed  Google Scholar 

Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond). 2015;2:17.

Article  PubMed  Google Scholar 

Wong TY, Cheung CMG, Larsen M, Sharma S, Simó R. Diabetic retinopathy. Nat Rev Dis Prim. 2016;2:1–17.

Google Scholar 

Ulbig MRW, Hamilton AMP. Factors influencing the natural history of diabetic retinopathy. Eye. 1993;7:242–9.

Article  PubMed  Google Scholar 

Porta M, Sjoelie AK, Chaturvedi N, Stevens L, Rottiers R, Veglio M, et al. Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia. 2001;44:2203–9.

Article  CAS  PubMed  Google Scholar 

Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM, UK Prospective Diabetes Study Group. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol. 2004;122:1631–40.

Article  PubMed  Google Scholar 

Chang YC, Wu WC. Dyslipidemia and Diabetic Retinopathy. Rev Diabet Stud. 2013;10:121–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou Y, Wang C, Shi K, Yin X. Relationship between dyslipidemia and diabetic retinopathy: A systematic review and meta-analysis. Medicine. 2018;97:e12283.

Article  PubMed  PubMed Central  Google Scholar 

Modjtahedi BS, Bose N, Papakostas TD, Morse L, Vavvas DG, Kishan AU. Lipids and Diabetic Retinopathy. Semin Ophthalmol. 2016;31:10–8.

Article  PubMed  Google Scholar 

Chou Y, Ma J, Su X, Zhong Y. Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy. Lipids Health Dis. 2020;19:241.

Article  PubMed  PubMed Central  Google Scholar 

van Leiden HA, Dekker JM, Moll AC, Nijpels G, Heine RJ, Bouter LM, et al. Risk Factors for Incident Retinopathy in a Diabetic and Nondiabetic Population: The Hoorn Study. Arch Ophthalmol. 2003;121:245–51.

Article  PubMed  Google Scholar 

Wang NK, Lai CC, Wang JP, Wu WC, Liu L, Yeh LK, et al. Risk factors associated with the development of retinopathy 10 yr after the diagnosis of juvenile-onset type 1 diabetes in Taiwan: a cohort study from the CGJDES. Pediatr Diabetes. 2016;17:407–16.

Article  CAS  PubMed  Google Scholar 

Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci. 1998;39:233–52.

CAS  PubMed  Google Scholar 

Klein R, Marino EK, Kuller LH, Polak JF, Tracy RP, Gottdiener JS, et al. The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol. 2002;86:84–90.

Article  PubMed  PubMed Central  Google Scholar 

Chung YR, Park SW, Choi SY, Kim SW, Moon KY, Kim JH, et al. Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy. Cardiovasc Diabetol. 2017;16:4.

Article  PubMed  PubMed Central  Google Scholar 

Wong TY, Cheung N, Tay WT, Wang JJ, Aung T, Saw SM, et al. Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 2008;115:1869–75.

Article  PubMed  Google Scholar 

Miljanovic B, Glynn RJ, Nathan DM, Manson JE, Schaumberg DA. A Prospective Study of Serum Lipids and Risk of Diabetic Macular Edema in Type 1 Diabetes. Diabetes 2004;53:2883–92.

Article  CAS  PubMed  Google Scholar 

Tan GS, Gan A, Sabanayagam C, Tham YC, Neelam K, Mitchell P, et al. Ethnic Differences in the Prevalence and Risk Factors of Diabetic Retinopathy: The Singapore Epidemiology of Eye Diseases Study. Ophthalmology 2018;125:529–36.

Article  PubMed  Google Scholar 

Keech AC, Mitchell P, Summanen PA, O’Day J, Davis TME, Moffitt MS, et al. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial. Lancet. 2007;370:1687–97.

Article  CAS  PubMed  Google Scholar 

Klein BE, Moss SE, Klein R, Surawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII. Relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology. 1991;98:1261–5.

Article  CAS  PubMed  Google Scholar 

Ioannidou E, Tseriotis VS, Tziomalos K. Role of lipid-lowering agents in the management of diabetic retinopathy. World J Diabetes. 2017;8:1–6.

Article  PubMed  PubMed Central  Google Scholar 

Kronenberg F. Lipoprotein(a). Handb Exp Pharm. 2022;270:201–32.

Article  CAS  Google Scholar 

Kang EYC, Chen TH, Garg SJ, Sun CC, Kang JH, Wu WC, et al. Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy. JAMA Ophthalmol. 2019;137:363–71.

Article  PubMed  PubMed Central  Google Scholar 

Vail D, Callaway NF, Ludwig CA, Saroj N, Moshfeghi DM. Lipid-Lowering Medications Are Associated with Lower Risk of Retinopathy and Ophthalmic Interventions among United States Patients with Diabetes. Am J Ophthalmol. 2019;207:378–84.

Article  CAS  PubMed  Google Scholar 

Kawasaki R, Konta T, Nishida K. Lipid-lowering medication is associated with decreased risk of diabetic retinopathy and the need for treatment in patients with type 2 diabetes: A real-world observational analysis of a health claims database. Diabetes, Obes Metab. 2018;20:2351–60.

Article  CAS  PubMed  Google Scholar 

Pranata R, Vania R, Victor AA. Statin reduces the incidence of diabetic retinopathy and its need for intervention: A systematic review and meta-analysis. Eur J Ophthalmol. 2021;31:1216–24.

Article  PubMed  Google Scholar 

Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849–61.

Article  CAS  PubMed  Google Scholar 

ACCORD Study Group, ACCORD Eye Study Group, Chew EY, Ambrosius WT, Davis MD, Danis RP, et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med. 2010;363:233–44.

Article  Google Scholar 

Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika. 1982;69:239–41.

Article  Google Scholar 

In J, Lee DK. Survival analysis: part II – applied clinical data analysis. Korean J Anesthesiol. 2019;72:441–57.

Article  PubMed  PubMed Central  Google Scholar 

Kuitunen I, Ponkilainen VT, Uimonen MM, Eskelinen A, Reito A. Testing the proportional hazards assumption in cox regression and dealing with possible non-proportionality in total joint arthroplasty research: methodological perspectives and review. BMC Musculoskelet Disord. 2021;22:489.

Article  PubMed  PubMed Central  Google Scholar 

Hancock MJ, Maher CG, Costa LdaCM, Williams CM. A guide to survival analysis for manual therapy clinicians and researchers. Man Ther. 2014;19:511–6.

Article  PubMed  Google Scholar 

Scott IU, Campochiaro PA, Newman NJ, Biousse V. Retinal Vascular Occlusions. Lancet. 2020;396:1927–40.

Article  PubMed  PubMed Central  Google Scholar 

Stroke - Causes and Risk Factors | NHLBI, NIH [Internet]. [cited 2023 Jun 19]. Available from: https://www.nhlbi.nih.gov/health/stroke/causes (2022).

Wilson PW. Established risk factors and coronary artery disease: the Framingham Study. Am J Hypertens. 1994;7:7S–12S.

Article  CAS  PubMed  Google Scholar 

Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY. Diabetic Retinopathy and the Risk of Coronary Heart Disease: The Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30:1742–6.

Article  PubMed  Google Scholar 

Miksenas H, Januzzi JL Jr, Natarajan P. Lipoprotein(a) and Cardiovascular Diseases. JAMA 2021;326:352–3.

Article  PubMed  Google Scholar 

Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, et al. Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association. Arteriosclerosis, Thrombosis, Vasc Biol. 2022;42:e48–60.

Article  CAS  Google Scholar 

Lu M, Lu Q, Zhang Y, Tian G. ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity. J Biomed Res. 2011;25:266–73.

Article  CAS  PubMed